Factors associated with conducting repeat HIV testing among pregnant women during the third trimester in Blantyre by Martha Kaula
Loading...
Date
28-10-21
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Kamuzu University of Health Sciencies
Abstract
Type of Study: A convergent parallel mixed-methods study design will be used to collect, analyse and interpret
quantitative and qualitative data.
Problem statement
Mother to child transmission of HIV during pregnancy remains high in Malawi currently at 13%
(15). A repeat HIV testing has been adopted in antenatal guidelines as one of the strategies in
eliminating paeditric HIV infection in Malawi since 2019 (2). However, there is scanty
information on repeat HIV testing among pregnant women and associated factors to its
implementation, hence the need for this study.
Objectives of the study
The overall objective of the study is to investigate the factors associated with conducting a repeat
HIV test among pregnant women in the third trimester specifically to;
1. determine the proportion of pregnant women who received a repeat HTC in the third
trimester in 2020.
2. assess clients’ characteristics that influence uptake of repeat HIV test among pregnant
women in the third trimester.
3. assess clinic organisational factors that influence uptake of repeat HIV test among pregnant
women in the third trimester.
4. explore intervention characteristics that influence uptake of repeat HIV test among
pregnant women in the third trimester.
5. identify strategies at service delivery level and health workforce that can increase uptake
of repeat HIV test in the third trimester.
Methodology
The study which will use case review for quantitative and exploratory cross-sectional design for
qualitative data.
Study setting
The study will be conducted in Blantyre district at Ndirande and Lirangwe primary health facilities.
Study population
Antenatal clients assisted from July 2019 to June 2020 will constitute population for the
quantitative approach. All the pregnant women, postnatal women, PMTCT providers and HCT
will comprise the population for the qualitative data.
Study period
The study will be conducted over a period of ten (10) months from June 2021 to March 2022.
Sample size
A total of 1024 records of antenatal women will be reviewed to collect quantitative data while 62
participants will be selected purposively and recruited for the qualitative data.
Data collection
The researchers will conduct all the survey and the interviews. A checklist will be used for clients’
case note reviews. Semi structured question guides will be used for in-depth interviews, key
informant interviews and focus group discussion to obtain qualitative data
Data management and analysis
Stata 14 will be used to analyse quantitative data and the results will be presented as descriptive
statistics. Qualitative data will be managed with NVivo 10.0 and analysed using thematic analysis
and results presented as themes.
Expected findings and dissemination of results.
It is expected that the study will identify the prevalence of repeat HIV testing among pregnant
women and its associated factors. The results of this study will be shared with the department of
HIV and AIDS (DHA) in the Ministry of Health, other stakeholders include Blantyre District
Health Office, College of Medicine Research and Ethics Committee (COMREC) and M-HIRST
coordinating team. Furthermore, the findings will be disseminated through meetings, reports,
international and local conferences and through publication in peer reviewed journals.
Ethical Considerations
Permission to conduct the study will be sought from College of Medicine Research and Ethics
Committee (COMREC) while institutional permission will be sought from Blantyre District Health
Office. Written informed consent for participation and digital recording of the discussions will be
obtained from each participant. Each participant will be informed that participation is voluntary
and can with draw their participation at any point without reprimands.
Possible constraints
The participants will be from Ndirande and Lirangwe health facilities and their catchment areas,
therefore the results cannot be generalized. However, the findings will contribute towards
improving uptake of repeat HIV testing among pregnant women in Blantyre.